Abstract:
:Most statistical methodology for phase III clinical trials focuses on the comparison of a single experimental treatment with a control. An increasing desire to reduce the time before regulatory approval of a new drug is sought has led to development of two-stage or sequential designs for trials that combine the definitive analysis associated with phase III with the treatment selection element of a phase II study. In this paper we consider a trial in which the most promising of a number of experimental treatments is selected at the first interim analysis. This considerably reduces the computational load associated with the construction of stopping boundaries compared to the approach proposed by Follman, Proschan and Geller (Biometrics 1994; 50: 325-336). The computational requirement does not exceed that for the sequential comparison of a single experimental treatment with a control. Existing methods are extended in two ways. First, the use of the efficient score as a test statistic makes the analysis of binary, normal or failure-time data, as well as adjustment for covariates or stratification straightforward. Second, the question of trial power is also considered, enabling the determination of sample size required to give specified power.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Stallard N,Todd Sdoi
10.1002/sim.1362subject
Has Abstractpub_date
2003-03-15 00:00:00pages
689-703issue
5eissn
0277-6715issn
1097-0258journal_volume
22pub_type
杂志文章abstract::In clinical trials, treatment comparisons are often performed by models that incorporate important prognostic factors. Since these models require complete covariate information on all patients, statisticians frequently resort to complete case analysis or to omission of an important covariate. A probability imputation ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780090707
更新日期:1990-07-01 00:00:00
abstract::Biostatistical concepts and methods apply to various problems arising in actual U.S. legal cases. These involve: measures of association, assessing the potential effect of omitted variables and the Peters-Belson approach to regression. In particular, we present the inapplicability of Fisher's exact test in the case wh...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780141505
更新日期:1995-08-15 00:00:00
abstract::Non-tumor cell-based model systems have recently gained interest in pharmacogenetic research as a hypothesis generating tool. The hypotheses generated from these model systems can be followed up in functional studies, or tested in individuals taking the same investigational agents. The current cellular phenotypes (e.g...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3649
更新日期:2009-09-20 00:00:00
abstract::Lower urinary tract symptoms can indicate the presence of urinary tract infection (UTI), a condition that if it becomes chronic requires expensive and time consuming care as well as leading to reduced quality of life. Detecting the presence and gravity of an infection from the earliest symptoms is then highly valuable...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6786
更新日期:2016-04-15 00:00:00
abstract::Clinical studies that involve the recording of two or more distinct and well-defined events on each subject give rise to multiple event data. Treatment comparisons are usually reported in univariate analyses of time to first event or number of events observed. However, this approach may not uncover the 'full story' of...
journal_title:Statistics in medicine
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1002/(sici)1097-0258(19970430)16:8<941::aid-sim
更新日期:1997-04-30 00:00:00
abstract::This paper develops methods of analysis for active extension clinical trials. Under this design, patients are randomized to treatment or placebo for a period of time (period 1), and then all patients receive treatment for an additional period of time (period 2). We assume a continuous outcome is measured at baseline a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2720
更新日期:2007-05-30 00:00:00
abstract::A Non-Parametric Maximum Likelihood approach to the estimation of relative risks in the context of disease mapping is discussed and a NPML approximation to conditional autoregressive models is proposed. NPML estimates have been compared to other proposed solutions (Maximum Likelihood via Monte Carlo Scoring, Hierarchi...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/1097-0258(20000915/30)19:17/18<2539::aid-s
更新日期:2000-09-15 00:00:00
abstract::We propose a joint model for a time-to-event outcome and a quantile of a continuous response repeatedly measured over time. The quantile and survival processes are associated via shared latent and manifest variables. Our joint model provides a flexible approach to handle informative dropout in quantile regression. A M...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6393
更新日期:2015-03-30 00:00:00
abstract::Estimates of transmission probabilities for sexually transmitted diseases historically come from studies of uninfected individuals exposed to those with a high disease prevalence (for example, prostitutes). However, changes in sexual behaviour, much of which relates to concerns about AIDS, has made identification of p...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780110502
更新日期:1992-03-01 00:00:00
abstract::Elevated plasma levels of apolipoproteins A1 (apoA1) and B (apoB) are important protective factors and risk factors, respectively, for atherosclerosis and coronary heart disease. It is well known that both apoA1 and apoB reveal strong familial aggregation. Our goal was to investigate whether exogenous variables influe...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/1097-0258(20001230)19:24<3345::aid-sim829>
更新日期:2000-12-30 00:00:00
abstract::In time-to-event analysis, the traditional summary measures have been based on the hazard function, survival function, quantile event time, restricted mean event time, and residual lifetime. Under competing risks, furthermore, typical summary measures have been the cause-specific hazard function and cumulative inciden...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8871
更新日期:2021-01-06 00:00:00
abstract::The Cochran-Armitage trend test has been used in case-control studies for testing genetic association. As the variance of the test statistic is a function of unknown parameters, e.g. disease prevalence and allele frequency, it must be estimated. The usual estimator combining data for cases and controls assumes they fo...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2250
更新日期:2006-09-30 00:00:00
abstract::In this paper, we consider fitting a flexible and interpretable additive regression model in a data-rich setting. We wish to avoid pre-specifying the functional form of the conditional association between each covariate and the response, while still retaining interpretability of the fitted functions. A number of recen...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7859
更新日期:2019-02-20 00:00:00
abstract::With the increasing availability of detailed clinical information, there is optimism that treatment choices can be selectively directed to those individuals most likely to benefit. While standard clinical trials can establish whether a treatment appears to be effective on average, subsequent work is needed to determin...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6138
更新日期:2014-07-30 00:00:00
abstract::Hypothesis testing, in which the null hypothesis specifies no difference between treatment groups, is an important tool in the assessment of new medical interventions. For randomized clinical trials, permutation tests that reflect the actual randomization are design-based analyses for such hypotheses. This means that ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(20000530)19:10<1319::aid-s
更新日期:2000-05-30 00:00:00
abstract::We discuss some of the statistical approaches to the design and analysis of phase I clinical trials in cancer. An attempt is made to identify the issues, particular to this type of trial, that should be addressed by an appropriate methodology. A brief review of schemes currently in use is provided together with our vi...
journal_title:Statistics in medicine
pub_type: 杂志文章,评审
doi:10.1002/sim.4780101104
更新日期:1991-11-01 00:00:00
abstract::Dependence between observations on a dichotomous variable renders invalid the usual chi-square tests of independence and inflates the variances of parameter estimates. Such a situation occurs, for example, when subjects consist of members of the same family or with repeated observations on the same person. In this pap...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780060408
更新日期:1987-06-01 00:00:00
abstract::Propensity score analysis is widely used in observational studies to adjust for confounding and estimate the causal effect of a treatment on the outcome. When the outcome is survival time, there are special considerations on the definition of the causal estimand, point, and variance estimation that have not been thoro...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7839
更新日期:2018-11-20 00:00:00
abstract::Population heterogeneity is frequently observed among patients' treatment responses in clinical trials because of various factors such as clinical background, environmental, and genetic factors. Different subpopulations defined by those baseline factors can lead to differences in the benefit or safety profile of a the...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7925
更新日期:2018-12-20 00:00:00
abstract::Screening and diagnostic tests are important in disease prevention or control. The predictive values of positive and negative (PPV and NPV) test results are two of four operational characteristics of a screening test. We review an existing method based on the generalized estimating equation (GEE) methodology for compa...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2332
更新日期:2006-07-15 00:00:00
abstract::Subjective judgements of complex variables are commonly recorded as ordered categorical data. The rank-invariant properties of such data are well known, and there are various statistical approaches to the analysis and modelling of ordinal data. This paper focuses on the non-additive property of ordered categorical dat...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19981230)17:24<2923::aid-s
更新日期:1998-12-30 00:00:00
abstract::We present methods for binomial regression when the outcome is determined using the results of a single diagnostic test with imperfect sensitivity and specificity. We present our model, illustrate it with the analysis of real data, and provide an example of WinBUGS program code for performing such an analysis. Conditi...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1656
更新日期:2004-04-15 00:00:00
abstract::Experimental designs with repeated measures allow response patterns over time (or dose) to be modelled and compared between different homogeneous groups. Issues in data analysis often focus on the pattern of variation of the repeated measures, the appropriateness of a univariate or multivariate analysis, and the shape...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780100116
更新日期:1991-01-01 00:00:00
abstract::One Sentence Summary: A Bayesian repeated measures model based on quantitative muscle strength data from a prospective Natural History Study was developed to determine disease progression and design clinical trials for GNE myopathy, a rare and slowly progressive muscle disease. GNE myopathy is a rare muscle disease ch...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8050
更新日期:2019-04-15 00:00:00
abstract::Paired count data usually arise in medicine when before and after treatment measurements are considered. In the present paper we assume that the correlated paired count data follow a bivariate Poisson distribution in order to derive the distribution of their difference. The derived distribution is shown to be the same...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2382
更新日期:2006-06-15 00:00:00
abstract::In this paper the following problem of clinical research is explored. Several potential new treatments are available for use against a certain disease. These are evaluated in a series of pilot studies which will constitute phase II clinical trials. The most promising will then be compared with a standard treatment in ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780050510
更新日期:1986-09-01 00:00:00
abstract::Mediation analyses can help us to understand the biological mechanism in which an exposure or treatment affects an outcome. Single mediator analyses have been used in various applications, but may not be appropriate for analyzing intricate mechanisms involving multiple mediators that affect each other. Thus, in this a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8485
更新日期:2020-05-15 00:00:00
abstract::This work is motivated by a longitudinal study of women and their ectopic pregnancy outcomes in Lund, Sweden. In this article, we review and apply the Liang-Zeger methodology to the Lund ectopic pregnancy data set. We further analyse the ectopic pregnancy data using conditional modelling approaches suggested by Rosner...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19971115)16:21<2403::aid-s
更新日期:1997-11-15 00:00:00
abstract::The treatment effect sizes that can be detected with sufficient power up to the different interim analyses constitute a clinically meaningful criterion for the selection of a group sequential test for a clinical trial. For any pre-specified sequence of effect sizes, it is possible to construct group sequential boundar...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1751
更新日期:2004-05-15 00:00:00
abstract::Many randomized clinical trials include a data and safety monitoring board (DSMB) that is responsible for reviewing accruing data, monitoring performance of the trial, assuring safety of the participants in the trial, and assessing the efficacy of treatment. The DSMB often makes recommendations about continuation of t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780120504
更新日期:1993-03-01 00:00:00